Principal Financial Group’s Niagen Bioscience NAGE Stock Holding History

Principal Financial Group’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$266K	Buy	83,248 +6,364	+8%	+$25.8K	﹤0.01%	2063
2026 Q1	$339K	Sell	76,884 -41,765	-35%	-$226K	﹤0.01%	2058
2025 Q4	$755K	Buy	118,649 +38,180	+47%	+$266K	﹤0.01%	1995
2025 Q3	$751K	Buy	80,469 +60,217	+297%	+$608K	﹤0.01%	1978
2025 Q2	$292K	Buy	+20,252	New	+$200K	﹤0.01%	2074
2021 Q4	–	Sell	-23,368	Closed	-$146K	–	2660
2021 Q3	$146K	Buy	23,368 +7,961	+52%	+$65.6K	﹤0.01%	2466
2021 Q2	$152K	Buy	+15,407	New	+$134K	﹤0.01%	2502
2021 Q1	–	Sell	-10,521	Closed	-$51K	–	2509
2020 Q4	$51K	Buy	+10,521	New	+$51.3K	﹤0.01%	2394

Other funds holding NAGE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Principal Financial Group's NAGE Position: Q2 2026 in Review

Principal Financial Group increased its Niagen Bioscience (NAGE) stake by 8.3% in Q2 2026, buying an estimated $25.8K and bringing the position to 83,248 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #2063.

Principal Financial Group first reported a position in NAGE in Q4 2020 and has held it in 8 quarters since. The position peaked at $755K in Q4 2025. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

Principal Financial Group held 83,248 shares of Niagen Bioscience worth $266K as of Q2 2026.
Principal Financial Group bought 6,364 Niagen Bioscience shares in Q2 2026, an estimated $25.8K.
Niagen Bioscience made up ﹤0.01% of Principal Financial Group's portfolio in Q2 2026, its #2063 holding.
Principal Financial Group first reported a position in Niagen Bioscience in Q4 2020 and has held it in 8 quarters since.
Principal Financial Group's Niagen Bioscience position peaked at $755K in Q4 2025.
140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.